Cervical cancer risk stratification based on nationwide electronic health data: a retrospective modelling and validation study from Estonia

Author:

Tisler Anna1,MA Andres Võrk1,Tammemägi Martin2,Ojavee Sven Erik3,Raag Mait1,Šavrova Aleksandra4,Nygard Mari5,Nygard Jan5,Stankunas Mindaugas6,Kivite-Urtane Anda7,Uusküla Anneli1

Affiliation:

1. University of Tartu

2. Brock University

3. University of Lausanne

4. North Estonia Medical Centre, Women's Clinic

5. Cancer Registry of Norway

6. Lithuanian University of Health Sciences

7. Institute of Public Health, Riga Stradins University

Abstract

Abstract

Transitioning to an individualized risk-based approach can significantly enhance cervical cancer screening programs. We aimed to derive and internally validate a prediction model for assessing the risk of cervical intraepithelial neoplasia grade 3 or higher (CIN3+) and cancer in women eligible for screening. This retrospective study utilized data from the Estonian electronic health records, including 517,884 women from the health insurance database and linked health registries. We employed Cox proportional hazard regression, incorporating reproductive and medical history variables (14 covariates), and utilized the least absolute shrinkage and selection operator (LASSO) for variable selection. A 10-fold cross-validation for internal validation of the model was used. The main outcomes were the performance of discrimination and calibration. Over the 8-year follow-up, we identified 1,326 women with cervical cancer and 5,929 with CIN3+, with absolute risks of 0.3% and 1.1%, respectively. The prediction model for CIN3+ and cervical cancer had good discriminative power and was well calibrated Harrell's C of 0.74 (0.73 - 0.74) (calibration slope 0.99 (0.94 - 1.03) and 0.67 (0.66 - 0.69) (calibration slope 0.96 (0.88 - 1.04) respectively. A developed model based on nationwide electronic health data showed potential utility for risk stratification to supplement screening efforts.

Publisher

Research Square Platform LLC

Reference28 articles.

1. Cancer screening. https://research-and-innovation.ec.europa.eu/strategy/support-policy-making/scientific-support-eu-policies/group-chief-scientific-advisors/cancer-screening_en#:~:text=As%20of%202020%2C%2025%20EU,and%2020%20for%20colorectal%20cancer.

2. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis;Bruni L;Lancet Glob Health,2022

3. Socio-economic inequality of utilization of cancer testing in Europe: A cross-sectional study;Bozhar H;Prev Med Rep,2022

4. Comparison of risk factors for squamous cell and adenocarcinomas of the cervix: a meta-analysis;BerringtonGonzález A;Br J Cancer,2004

5. The current status of risk-stratified breast screening;Clift AK;British Journal of Cancer 2021,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3